Payment overview · 2025
General Payments
$21.15
1 reported records · 1 companies
Healthcare provider profile · identity verified
Peter Patrick Acosta, M.D.
Allopathic & Osteopathic Physicians|Family Medicine · BOERNE, TX · NPI 1083637888
Verified facts
What the public records show
CMS Open Payments records show Peter Patrick Acosta, M.D. received $21.15 in general payments during 2025 across 1 reported records.
Neurocrine BioSciences, Inc. accounted for 100.0% of that reported general-payment amount.
The Open Payments records used for this analysis explicitly named 1 associated product.
These records do not establish that a payment influenced prescribing or medical care.
Separate record types
Research & Ownership
Research Payments (direct recipient): not present in the loaded data
Associated Research Funding (for example, named PI): not present in the loaded data
Ownership / Investment: not present in the loaded data
These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.
Who paid this doctor?
Companies in 2025 General Payments
| Reported company | Canonical company | Amount | Share | Records | Year |
|---|---|---|---|---|---|
| Neurocrine BioSciences, Inc. | Unresolved — no canonical attribution shown | $21.15 | 100.0% | 1 | 2025 |
What were the payments for?
Payment categories
| Category | Amount | Records |
|---|---|---|
| Food and Beverage | $21.15 | 1 |
A meal, consulting fee, royalty, and travel payment describe different kinds of reported relationships and should not be interpreted as equivalent.
Analysis 1 · Payment-linked products
Products named in Open Payments records
| Reported product | Type | Reported company | Related amount* | Records | Year |
|---|---|---|---|---|---|
| INGREZZA Normalized: ingrezza |
Drug | Neurocrine BioSciences, Inc. | $21.15 | 1 | 2025 |
Source payment records
|
|||||
* Product-associated amounts are non-additive because one payment record may name more than one product.
These products were named on specific Open Payments records. A named product does not show that the payment influenced treatment or prescribing.
Public prescribing for products named in payments
No exact normalized or approved-alias overlap was found in the loaded Part D year. This does not mean the doctor never prescribed the product.
The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.
Analysis 2 · Same-company prescribing overlap
Drugs reported in other payments from the same company that also appear in Medicare Part D
This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.
No publishable same-company prescribing overlap was found in the loaded Part D year. This does not mean the doctor never prescribed a drug reported elsewhere by a paying company.
These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.
Public Medicare Part D data
Provider-and-drug rows loaded for 2024
| Brand | Generic | Claims | Beneficiaries |
|---|---|---|---|
| Atorvastatin Calcium | Atorvastatin Calcium | 749 | 118 |
| Levothyroxine Sodium | Levothyroxine Sodium | 433 | 68 |
| Eliquis | Apixaban | 411 | 45 |
| Amlodipine Besylate | Amlodipine Besylate | 395 | 74 |
| Furosemide | Furosemide | 376 | 68 |
| Sertraline Hcl | Sertraline Hcl | 360 | 70 |
| Gabapentin | Gabapentin | 346 | 63 |
| Mirtazapine | Mirtazapine | 315 | 61 |
| Divalproex Sodium | Divalproex Sodium | 313 | 53 |
| Metformin Hcl | Metformin Hcl | 313 | 41 |
| Potassium Chloride | Potassium Chloride | 287 | 47 |
| Lisinopril | Lisinopril | 258 | 56 |
| Metoprolol Tartrate | Metoprolol Tartrate | 250 | 48 |
| Levetiracetam | Levetiracetam | 238 | 36 |
| Donepezil Hcl | Donepezil Hcl | 236 | 35 |
| Pantoprazole Sodium | Pantoprazole Sodium | 224 | 42 |
| Memantine Hcl | Memantine Hcl | 223 | 37 |
| Carvedilol | Carvedilol | 202 | 35 |
| Metoprolol Succinate | Metoprolol Succinate | 191 | 37 |
| Famotidine | Famotidine | 163 | 33 |
| Trazodone Hcl | Trazodone Hcl | 159 | 40 |
| Tramadol Hcl | Tramadol Hcl | 156 | 56 |
| Clopidogrel | Clopidogrel Bisulfate | 154 | 29 |
| Olanzapine | Olanzapine | 150 | 25 |
| Tamsulosin Hcl | Tamsulosin Hcl | 150 | 32 |
| Buspirone Hcl | Buspirone Hcl | 145 | 29 |
| Latanoprost | Latanoprost | 135 | 27 |
| Montelukast Sodium | Montelukast Sodium | 130 | 22 |
| Omeprazole | Omeprazole | 129 | 26 |
| Risperidone | Risperidone | 126 | 21 |
| Quetiapine Fumarate | Quetiapine Fumarate | 121 | 23 |
| Fluticasone Propionate | Fluticasone Propionate | 120 | 35 |
| Myrbetriq | Mirabegron | 118 | 12 |
| Escitalopram Oxalate | Escitalopram Oxalate | 112 | 21 |
| Spironolactone | Spironolactone | 111 | 18 |
| Nifedipine Er | Nifedipine | 110 | 24 |
| Hydralazine Hcl | Hydralazine Hcl | 102 | 33 |
| Glipizide | Glipizide | 86 | 15 |
| Carbidopa-Levodopa | Carbidopa/Levodopa | 82 | 13 |
| Lamotrigine | Lamotrigine | 82 | suppressed |
| Xarelto | Rivaroxaban | 81 | suppressed |
| Basaglar Kwikpen U-100 | Insulin Glargine,hum.Rec.Anlog | 78 | 16 |
| Losartan Potassium | Losartan Potassium | 78 | 23 |
| Farxiga | Dapagliflozin Propanediol | 76 | suppressed |
| Fluoxetine Hcl | Fluoxetine Hcl | 76 | 12 |
| Duloxetine Hcl | Duloxetine Hcl | 75 | 13 |
| Lactulose | Lactulose | 75 | 25 |
| Ondansetron Hcl | Ondansetron Hcl | 70 | 54 |
| Permethrin | Permethrin | 69 | 56 |
| Tradjenta | Linagliptin | 68 | suppressed |
| Hydrochlorothiazide | Hydrochlorothiazide | 65 | suppressed |
| Ipratropium-Albuterol | Ipratropium/Albuterol Sulfate | 63 | 33 |
| Alendronate Sodium | Alendronate Sodium | 60 | suppressed |
| Invega Sustenna | Paliperidone Palmitate | 60 | suppressed |
| Acetaminophen-Codeine | Acetaminophen With Codeine | 59 | 17 |
| Azithromycin | Azithromycin | 59 | 39 |
| Jardiance | Empagliflozin | 58 | suppressed |
| Hydroxyzine Hcl | Hydroxyzine Hcl | 57 | 37 |
| Januvia | Sitagliptin Phosphate | 57 | suppressed |
| Sucralfate | Sucralfate | 57 | suppressed |
| Simvastatin | Simvastatin | 56 | suppressed |
| Pravastatin Sodium | Pravastatin Sodium | 55 | suppressed |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 55 | 30 |
| Kapspargo Sprinkle | Metoprolol Succinate | 53 | suppressed |
| Lantus Solostar | Insulin Glargine,hum.Rec.Anlog | 53 | 18 |
| Celecoxib | Celecoxib | 52 | suppressed |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 52 | 16 |
| Finasteride | Finasteride | 51 | suppressed |
| Isosorbide Mononitrate Er | Isosorbide Mononitrate | 51 | suppressed |
| Oxcarbazepine | Oxcarbazepine | 51 | suppressed |
| Aripiprazole | Aripiprazole | 49 | suppressed |
| Enalapril Maleate | Enalapril Maleate | 49 | suppressed |
| Anastrozole | Anastrozole | 48 | suppressed |
| Pregabalin | Pregabalin | 47 | 12 |
| Topiramate | Topiramate | 47 | suppressed |
| Albuterol Sulfate Hfa | Albuterol Sulfate | 45 | 37 |
| Cefuroxime | Cefuroxime Axetil | 42 | 31 |
| Nitrofurantoin Mono-Macro | Nitrofurantoin Monohyd/M-Cryst | 42 | 29 |
| Prednisone | Prednisone | 42 | 17 |
| Oxybutynin Chloride | Oxybutynin Chloride | 41 | suppressed |
| Baclofen | Baclofen | 39 | suppressed |
| Clonidine Hcl | Clonidine Hcl | 38 | 12 |
| Doxycycline Hyclate | Doxycycline Hyclate | 38 | 27 |
| Insulin Glargine-Yfgn | Insulin Glargine-Yfgn | 38 | 15 |
| Lacosamide | Lacosamide | 38 | suppressed |
| Amiodarone Hcl | Amiodarone Hcl | 36 | suppressed |
| Meloxicam | Meloxicam | 36 | suppressed |
| Autoshield Duo Pen Needle | Pen Needle,dual Safety,diabetc | 35 | suppressed |
| Valproic Acid | Valproic Acid (As Sodium Salt) | 35 | suppressed |
| Bumetanide | Bumetanide | 33 | suppressed |
| Propranolol Hcl | Propranolol Hcl | 33 | suppressed |
| Sulfamethoxazole-Trimethoprim | Sulfamethoxazole/Trimethoprim | 33 | 28 |
| Fenofibrate | Fenofibrate Nanocrystallized | 32 | suppressed |
| Insulin Lispro Kwikpen U-100 | Insulin Lispro | 32 | 11 |
| Medroxyprogesterone Acetate | Medroxyprogesterone Acetate | 32 | suppressed |
| Midodrine Hcl | Midodrine Hcl | 32 | suppressed |
| Entresto | Sacubitril/Valsartan | 31 | suppressed |
| Nystatin | Nystatin | 31 | 20 |
| Rivastigmine | Rivastigmine | 31 | suppressed |
| Sevelamer Carbonate | Sevelamer Carbonate | 31 | suppressed |
| Trospium Chloride | Trospium Chloride | 31 | suppressed |
| Cephalexin | Cephalexin | 30 | 22 |
| Ezetimibe | Ezetimibe | 29 | suppressed |
| Insulin Aspart Flexpen | Insulin Aspart | 29 | suppressed |
| Humalog Kwikpen U-100 | Insulin Lispro | 28 | suppressed |
| Lovastatin | Lovastatin | 28 | suppressed |
| Meclizine Hcl | Meclizine Hcl | 28 | suppressed |
| Carbamazepine | Carbamazepine | 27 | suppressed |
| Ciclopirox | Ciclopirox | 27 | 12 |
| Hydroxyzine Pamoate | Hydroxyzine Pamoate | 27 | 18 |
| Clozapine | Clozapine | 26 | suppressed |
| Janumet | Sitagliptin Phos/Metformin Hcl | 26 | suppressed |
| Nyamyc | Nystatin | 26 | 11 |
| Tizanidine Hcl | Tizanidine Hcl | 26 | suppressed |
| Torsemide | Torsemide | 26 | suppressed |
| Trulicity | Dulaglutide | 26 | suppressed |
| Clonazepam | Clonazepam | 25 | suppressed |
| Methocarbamol | Methocarbamol | 24 | suppressed |
| Oxybutynin Chloride Er | Oxybutynin Chloride | 24 | suppressed |
| Divalproex Sodium Er | Divalproex Sodium | 23 | suppressed |
| Pioglitazone Hcl | Pioglitazone Hcl | 23 | suppressed |
| Timolol Maleate | Timolol Maleate | 23 | suppressed |
| Valsartan | Valsartan | 23 | suppressed |
| Ciprofloxacin Hcl | Ciprofloxacin Hcl | 22 | 20 |
| Venlafaxine Hcl Er | Venlafaxine Hcl | 22 | suppressed |
| Bydureon Bcise | Exenatide Microspheres | 21 | suppressed |
| Citalopram Hbr | Citalopram Hydrobromide | 21 | suppressed |
| Paliperidone Er | Paliperidone | 21 | suppressed |
| Phenytoin Sodium Extended | Phenytoin Sodium Extended | 21 | suppressed |
| Allopurinol | Allopurinol | 20 | suppressed |
| Amiloride Hcl | Amiloride Hcl | 20 | suppressed |
| Bupropion Xl | Bupropion Hcl | 20 | suppressed |
| Ibuprofen | Ibuprofen | 20 | 11 |
| Levofloxacin | Levofloxacin | 20 | 15 |
| Prazosin Hcl | Prazosin Hcl | 20 | suppressed |
| Scopolamine | Scopolamine | 20 | suppressed |
| Albuterol Sulfate | Albuterol Sulfate | 19 | suppressed |
| Sodium Chloride | 0.9 % Sodium Chloride | 19 | 13 |
| Constulose | Lactulose | 18 | suppressed |
| Hydrocodone-Acetaminophen | Hydrocodone/Acetaminophen | 18 | 12 |
| Levemir Flexpen | Insulin Detemir | 18 | suppressed |
| Promethazine Hcl | Promethazine Hcl | 18 | 18 |
| Hydroxychloroquine Sulfate | Hydroxychloroquine Sulfate | 17 | suppressed |
| Paroxetine Hcl | Paroxetine Hcl | 17 | suppressed |
| Toujeo Solostar | Insulin Glargine,hum.Rec.Anlog | 17 | suppressed |
| Trelegy Ellipta | Fluticasone/Umeclidin/Vilanter | 17 | suppressed |
| Amoxicillin | Amoxicillin | 16 | 11 |
| Arnuity Ellipta | Fluticasone Furoate | 16 | suppressed |
| Memantine Hcl Er | Memantine Hcl | 16 | suppressed |
| Metoclopramide Hcl | Metoclopramide Hcl | 16 | suppressed |
| Brimonidine Tartrate | Brimonidine Tartrate | 15 | suppressed |
| Budesonide-Formoterol Fumarate | Budesonide/Formoterol Fumarate | 15 | suppressed |
| Clobazam | Clobazam | 15 | suppressed |
| Fenofibrate | Fenofibrate,micronized | 15 | suppressed |
| Nitrofurantoin | Nitrofurantoin Macrocrystal | 15 | suppressed |
| Nystop | Nystatin | 15 | 12 |
| Phenobarbital | Phenobarbital | 15 | suppressed |
| Ropinirole Hcl | Ropinirole Hcl | 15 | suppressed |
| Tivicay | Dolutegravir Sodium | 15 | suppressed |
| Budesonide | Budesonide | 14 | suppressed |
| Cilostazol | Cilostazol | 14 | suppressed |
| Diclofenac Sodium | Diclofenac Sodium | 14 | 12 |
| Doxycycline Monohydrate | Doxycycline Monohydrate | 14 | suppressed |
| Lorazepam | Lorazepam | 14 | 13 |
| Lumigan | Bimatoprost | 14 | suppressed |
| Nurtec Odt | Rimegepant Sulfate | 14 | suppressed |
| Amitriptyline Hcl | Amitriptyline Hcl | 13 | suppressed |
| Carbamazepine Er | Carbamazepine | 13 | suppressed |
| Ceftriaxone | Ceftriaxone Sodium | 13 | suppressed |
| Dapagliflozin | Dapagliflozin Propanediol | 13 | suppressed |
| Icosapent Ethyl | Icosapent Ethyl | 13 | suppressed |
| Lokelma | Sodium Zirconium Cyclosilicate | 13 | suppressed |
| Losartan-Hydrochlorothiazide | Losartan/Hydrochlorothiazide | 13 | suppressed |
| Methimazole | Methimazole | 13 | suppressed |
| Novolin N Flexpen | Insulin Nph Human Isophane | 13 | suppressed |
| Novolog Flexpen | Insulin Aspart | 13 | suppressed |
| Dorzolamide-Timolol | Dorzolamide Hcl/Timolol Maleat | 12 | suppressed |
| Esomeprazole Magnesium | Esomeprazole Magnesium | 12 | suppressed |
| Fosinopril Sodium | Fosinopril Sodium | 12 | suppressed |
| Gemtesa | Vibegron | 12 | suppressed |
| Lisinopril-Hydrochlorothiazide | Lisinopril/Hydrochlorothiazide | 12 | suppressed |
| Olanzapine Odt | Olanzapine | 12 | suppressed |
| Omega-3 Acid Ethyl Esters | Omega-3 Acid Ethyl Esters | 12 | suppressed |
| Primidone | Primidone | 12 | suppressed |
| Rivastigmine | Rivastigmine Tartrate | 12 | suppressed |
| Vitamin D2 | Ergocalciferol (Vitamin D2) | 12 | suppressed |
| Acetazolamide | Acetazolamide | 11 | suppressed |
| Atropine Sulfate | Atropine Sulfate | 11 | 11 |
| Calcitriol | Calcitriol | 11 | suppressed |
| Insulin Lispro | Insulin Lispro | 11 | suppressed |
| Ozempic | Semaglutide | 11 | suppressed |
| Xifaxan | Rifaximin | 11 | suppressed |
Timeline
Payment and prescribing data by year
Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.
| Year | General Payments | Main payer | Explicit products | Company overlaps | Part D coverage |
|---|---|---|---|---|---|
| 2025 | $21.15 · 1 records | Neurocrine BioSciences, Inc. | INGREZZA | — | — |
| 2024 | — | — | — | — | Complete |
Questions to ask
Questions you could discuss with your doctor
- Are there reasonable alternatives I should understand when we discuss treatment options?
- How should I interpret the industry-payment records shown here in the context of my care?
These are general questions generated from reviewed templates. They are not personalized medical advice.
Sources and limitations
How to read this page
- Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
- Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
- Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
- Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
- When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.
Loaded source releases
| Dataset | Year | Publication | Source |
|---|---|---|---|
| CMS Open Payments — General Payments | 2025 | 2026-06-30 | Original source |
| Medicare Part D Prescribers by Provider and Drug | 2024 | 2026-05-06 | Original source |
| NPPES Data Dissemination V2 | current / reference data | 2026-08-10 | Original source |
Full methodology · Questions & answers · Report a possible error